Goutman S, Boss J, Jang D, Piecuch C, Farid H, Batra M
J Neurol Sci. 2024; 457:122899.
PMID: 38278093
PMC: 11060628.
DOI: 10.1016/j.jns.2024.122899.
Burton B, Collins K, Brooks J, Marx K, Renner A, Wilcox K
PLoS One. 2023; 18(3):e0278793.
PMID: 36893156
PMC: 9997973.
DOI: 10.1371/journal.pone.0278793.
Spencer P, Palmer V, Kisby G, Lagrange E, Horowitz B, Angues R
Front Neurosci. 2023; 17:1005096.
PMID: 36860617
PMC: 9969898.
DOI: 10.3389/fnins.2023.1005096.
Li W, Pandya D, Pasternack N, Garcia-Montojo M, Henderson L, Kozak C
Neurotherapeutics. 2022; 19(4):1085-1101.
PMID: 35415778
PMC: 9587200.
DOI: 10.1007/s13311-022-01233-8.
Quinn A, Phillips C, Violi J, Steele J, Johnson M, Westerhausen M
Amino Acids. 2021; 53(9):1351-1359.
PMID: 34283312
DOI: 10.1007/s00726-021-03049-w.
Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis.
Ra D, Sa B, Sl B, Js M, Sj M, DA D
Neurotox Res. 2021; 39(1):81-106.
PMID: 33547590
PMC: 7904546.
DOI: 10.1007/s12640-020-00302-0.
Etiology of Retinal and Cerebellar Pathology in Western Pacific Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex.
Spencer P
Eye Brain. 2020; 12:97-104.
PMID: 32765151
PMC: 7381794.
DOI: 10.2147/EB.S260823.
Hypothesis: Etiologic and Molecular Mechanistic Leads for Sporadic Neurodegenerative Diseases Based on Experience With Western Pacific ALS/PDC.
Spencer P
Front Neurol. 2019; 10:754.
PMID: 31417480
PMC: 6685391.
DOI: 10.3389/fneur.2019.00754.
Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects.
Myhre O, Eide D, Kleiven S, Utkilen H, Hofer T
Sci Rep. 2018; 8(1):2308.
PMID: 29396538
PMC: 5797144.
DOI: 10.1038/s41598-018-20327-y.
The Potential Role of BMAA in Neurodegeneration.
Caller T, Henegan P, Stommel E
Neurotox Res. 2017; 33(1):222-226.
PMID: 28612294
DOI: 10.1007/s12640-017-9752-7.
A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans.
Chernoff N, Hill D, Diggs D, Faison B, Francis B, Lang J
J Toxicol Environ Health B Crit Rev. 2017; 20(4):1-47.
PMID: 28598725
PMC: 6503681.
DOI: 10.1080/10937404.2017.1297592.
Cyanobacterial Neurotoxins: Their Occurrence and Mechanisms of Toxicity.
Rodgers K, Main B, Samardzic K
Neurotox Res. 2017; 33(1):168-177.
PMID: 28585115
DOI: 10.1007/s12640-017-9757-2.
BMAA and Neurodegenerative Illness.
Cox P, Kostrzewa R, Guillemin G
Neurotox Res. 2017; 33(1):178-183.
PMID: 28540663
DOI: 10.1007/s12640-017-9753-6.
Methods for the Chemical Analysis of β-N-Methylamino-L-A lanine: What Is Known and What Remains to Be Determined.
Banack S, Murch S
Neurotox Res. 2017; 33(1):184-191.
PMID: 28474174
DOI: 10.1007/s12640-017-9744-7.
TDP-43/FUS in motor neuron disease: Complexity and challenges.
Guerrero E, Wang H, Mitra J, Hegde P, Stowell S, Liachko N
Prog Neurobiol. 2016; 145-146:78-97.
PMID: 27693252
PMC: 5101148.
DOI: 10.1016/j.pneurobio.2016.09.004.
Molybdenum Deficiency Produces Motor Nervous Effects That Are Consistent with Amyotrophic Lateral Sclerosis.
Bourke C
Front Neurol. 2016; 7:28.
PMID: 27014182
PMC: 4782119.
DOI: 10.3389/fneur.2016.00028.
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
Cox P, Davis D, Mash D, Metcalf J, Banack S
Proc Biol Sci. 2016; 283(1823).
PMID: 26791617
PMC: 4795023.
DOI: 10.1098/rspb.2015.2397.
Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011.
Henry K, Fagliano J, Jordan H, Rechtman L, Kaye W
Am J Epidemiol. 2015; 182(6):512-9.
PMID: 26041711
PMC: 4564938.
DOI: 10.1093/aje/kwv095.
Detection of cyanotoxins, β-N-methylamino-L-alanine and microcystins, from a lake surrounded by cases of amyotrophic lateral sclerosis.
Banack S, Caller T, Henegan P, Haney J, Murby A, Metcalf J
Toxins (Basel). 2015; 7(2):322-36.
PMID: 25643180
PMC: 4344626.
DOI: 10.3390/toxins7020322.
Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme.
Delzor A, Couratier P, Boumediene F, Nicol M, Druet-Cabanac M, Paraf F
BMJ Open. 2014; 4(8):e005528.
PMID: 25180055
PMC: 4156816.
DOI: 10.1136/bmjopen-2014-005528.